Clinical trials
Phase 2/3 Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2012 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mandos LLC | 2 |
| Ain Shams University | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Peking University First Hospital | 1 |
| Progenics Pharmaceuticals, Inc. | 1 |
| Rheumazentrum Ruhrgebiet | 1 |
| Stanford University | 1 |
| Swedish Orphan Biovitrum | 1 |
| The Stone Research Foundation for Sports Medicine and Arthritis | 1 |
| The University of Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease | 17 |
| Cognitive Dysfunction | 2 |
| Deglutition Disorders | 2 |
| Mobility Limitation | 2 |
| Niemann-Pick Disease, Type C | 2 |
| Anemia, Aplastic | 1 |
| Arthritis, Rheumatoid | 1 |
| Bone Marrow Failure Disorders | 1 |
| Dementia | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.